Trial
NCT06488716
A Study to Evaluate the Safety, Pharmacokinetics, and Activity of RO7759065 as a Single Agent and in Combination With Atezolizumab in Patients With Locally Advanced or Metastatic Solid Tumors
Phase ITERMINATEDSAFETYConfidence: MEDIUM
Sponsor
Genentech, Inc.
Collaborators
—
Condition
Solid Tumour
Intervention
RO7759065
Why stopped
Following a thorough review of safety data, preliminary efficacy data and an evaluation of overall risk-benefit, Sponsor made the decision to end the study.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-12-24